194 related articles for article (PubMed ID: 15466414)
21. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
[TBL] [Abstract][Full Text] [Related]
22. Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.
Liu JR; Baek C; Han XH; Shoureshi P; Soriano SG
Br J Anaesth; 2013 Jun; 110 Suppl 1():i3-9. PubMed ID: 23533250
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1).
Kim JW; Lee JE; Kim MJ; Cho EG; Cho SG; Choi EJ
J Biol Chem; 2003 Apr; 278(16):13995-4001. PubMed ID: 12584189
[TBL] [Abstract][Full Text] [Related]
24. A β1/2 adrenergic receptor-sensitive intracellular signaling pathway modulates CCL2 production in cultured spinal astrocytes.
Morioka N; Abe H; Araki R; Matsumoto N; Zhang FF; Nakamura Y; Hisaoka-Nakashima K; Nakata Y
J Cell Physiol; 2014 Mar; 229(3):323-32. PubMed ID: 24037783
[TBL] [Abstract][Full Text] [Related]
25. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
26. Cyclic AMP suppresses matrix metalloproteinase-1 expression through inhibition of MAPK and GSK-3beta.
Park CH; Moon Y; Shin CM; Chung JH
J Invest Dermatol; 2010 Aug; 130(8):2049-56. PubMed ID: 20357815
[TBL] [Abstract][Full Text] [Related]
27. Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells.
Malchinkhuu E; Sato K; Horiuchi Y; Mogi C; Ohwada S; Ishiuchi S; Saito N; Kurose H; Tomura H; Okajima F
Oncogene; 2005 Oct; 24(44):6676-88. PubMed ID: 16007180
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.
Sun Y; Kim NH; Yang H; Kim SH; Huh SO
Mol Cells; 2011 May; 31(5):483-9. PubMed ID: 21499833
[TBL] [Abstract][Full Text] [Related]
29. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
31. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
32. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling.
Le Floch N; Rivat C; De Wever O; Bruyneel E; Mareel M; Dale T; Gespach C
FASEB J; 2005 Jan; 19(1):144-6. PubMed ID: 15507471
[TBL] [Abstract][Full Text] [Related]
33. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
34. Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq.
Fan G; Ballou LM; Lin RZ
J Biol Chem; 2003 Dec; 278(52):52432-6. PubMed ID: 14561750
[TBL] [Abstract][Full Text] [Related]
35. Serine-threonine kinase 38 is regulated by glycogen synthase kinase-3 and modulates oxidative stress-induced cell death.
Enomoto A; Kido N; Ito M; Takamatsu N; Miyagawa K
Free Radic Biol Med; 2012 Jan; 52(2):507-15. PubMed ID: 22142472
[TBL] [Abstract][Full Text] [Related]
36. GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock.
Noh KT; Park YM; Cho SG; Choi EJ
Exp Cell Res; 2011 Jul; 317(12):1663-8. PubMed ID: 21515258
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
Liao X; Zhang L; Thrasher JB; Du J; Li B
Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
[TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase-3β is critical for interferon-α-induced serotonin uptake in human Jurkat T cells.
Tsao CW; Lin CF; Wu HT; Ma CT; Huang WC; Hsieh CY; Choi PC; Young KC
J Cell Physiol; 2012 Jun; 227(6):2556-66. PubMed ID: 21898401
[TBL] [Abstract][Full Text] [Related]
40. c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis.
Walker NM; Mazzoni SM; Vittal R; Fingar DC; Lama VN
J Biol Chem; 2018 Nov; 293(44):17229-17239. PubMed ID: 30217824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
